Quality of Life and Behavioral Change of Retired Persons
Launched by INSTITUT PASTEUR DE LILLE · May 21, 2024
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
The study will be carried out on healthy volunteers, retired.
The main objective of the study is to evaluate the effect of a health check-up followed by a collective "coaching" type of support on the quality of life of retired people 12 months after the end of the coaching sessions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Man or Woman;
- • Retired;
- • Having the desire to change his/her lifestyle;
- • Agreeing to follow the constraints generated by the study (presence during the coaching sessions and the final assessment).
- • Having signed the informed consent form;
- • Social insured;
- Exclusion Criteria:
- • Presenting a pathology requiring a complementary assessment and/or the implementation of a treatment that could prevent the realization of the coaching or that could modify its effect;
- • Subject participating in another clinical study or in period of exclusion from another study;
- • Subject deprived of liberty;
- • Subject under judicial protection measure;
- • Whose main investigator or a qualified co-investigator judges that the state of health or the concomitant treatments are not compatible with the good progress of the clinical study;.
About Institut Pasteur De Lille
Institut Pasteur de Lille is a prominent research institution in France dedicated to advancing medical science and public health through innovative research and clinical trials. Recognized for its expertise in infectious diseases, immunology, and vaccine development, the institute fosters collaboration among multidisciplinary teams to translate scientific discoveries into effective therapies and preventive measures. With a strong commitment to ethical standards and patient safety, Institut Pasteur de Lille plays a crucial role in addressing global health challenges and enhancing the quality of care through rigorous clinical research and development initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lille, Nord, France
Patients applied
Trial Officials
Jean-Michel LECERF, MD
Principal Investigator
Institut Pasteur de Lille - NutrInvest
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported